Photodynamic therapy for choroidal neovascularization secondary to choroidal nevus.
OBJECTIVE
To describe a patient treated with photodynamic therapy for subfoveal choroidal neovascularization secondary to choroidal nevus.


METHODS
Interventional case report.


METHODS
A 61-year-old woman presented with subfoveal choroidal neovascularization secondary to choroidal nevus and best-corrected visual acuity of 20/50. The choroidal neovascularization was treated with two verteporfin photodynamic therapy sessions, separated by 3 months.


RESULTS
The choroidal neovascularization was occluded after two sessions. Best-corrected visual acuity improved to 20/25 and remained stable throughout an 18-month follow-up.


CONCLUSIONS
Photodynamic therapy seems to be an effective treatment for subfoveal choroidal neovascularization secondary to choroidal nevus.
Stanescu
Dinu
D
Department of Ophthalmology, Saint-Pierre University Hospital, Brussels, Belgium.
Wattenberg
Sandrine
S
Cohen
Salomon Y
SY
D002830:Choroid Neoplasms / Q000150:complications*; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D008875:Middle Aged; D009508:Nevus, Pigmented / Q000150:complications*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D000077362:Verteporfin; D014792:Visual Acuity
D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin